EICHOR
● Active Not Recruiting
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
Condition: SGA, Turner Syndrome, Noonan Syndrome, ISS · Sponsor: Novo Nordisk A/S
About this study
The study compares two medicines for treatment of children born small and who stay small, or with Turner Syndrome, Noonan Syndrome, or idiopathic short stature. The purpose of the study is to see how well treatment with somapacitan works compared to treatment with Norditropin®. Somapacitan is a new medicine, and Norditropin® is a medicine doctors can already prescribe in some countries. The study will last for upto 5.5 years. The participants will either get somapacitan once a week up to 5.5 years or Norditropin® once a day for 1 year followed by somapacitan once a week for up to 4.5 years. Which treatment the participants get is decided by chance.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (199)
| Univ of AL at Birmingham_BRM | Birmingham, Alabama, United States | — |
| Children's Hospital Los Angeles - Endocrinology | Los Angeles, California, United States | — |
| Sutter Valley Med Fdt Ped Endo | Sacramento, California, United States | — |
| Rady Childrens Hosp San Diego | San Diego, California, United States | — |
| Children's Hospital Colorado | Aurora, Colorado, United States | — |
| Rocky Mt Ped and Endo | Centennial, Colorado, United States | — |
| Ped Endo Assoc PC-G.V | Greenwood Village, Colorado, United States | — |
| Nemours/AI duPont Hosp-Chld | Wilmington, Delaware, United States | — |
| Childrens National Medical Ctr | Washington D.C., District of Columbia, United States | — |
| Nemours Chld Clnc Jacksonville | Jacksonville, Florida, United States | — |
| Atlanta Diabetes Associates | Atlanta, Georgia, United States | — |
| St. Luke's Children's Endo | Boise, Idaho, United States | — |
+ 187 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05330325